Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 44 entries
Sorted by: Best Match Show Resources per page
Generation of neutral atomic beams utilizing photodetachment by high power diode laser stacks.

The Review of scientific instruments

O'Connor AP, Grussie F, Bruhns H, de Ruette N, Koenning TP, Miller KA, Savin DW, Stützel J, Urbain X, Kreckel H.
PMID: 26628128
Rev Sci Instrum. 2015 Nov;86(11):113306. doi: 10.1063/1.4934873.

We demonstrate the use of high power diode laser stacks to photodetach fast hydrogen and carbon anions and produce ground term neutral atomic beams. We achieve photodetachment efficiencies of ∼7.4% for H(-) at a beam energy of 10 keV...

Cite
O'Connor AP, Grussie F, Bruhns H, et al. Generation of neutral atomic beams utilizing photodetachment by high power diode laser stacks. Rev Sci Instrum. 2015;86(11):113306doi: 10.1063/1.4934873.
O'Connor, A. P., Grussie, F., Bruhns, H., de Ruette, N., Koenning, T. P., Miller, K. A., Savin, D. W., Stützel, J., Urbain, X., & Kreckel, H. (2015). Generation of neutral atomic beams utilizing photodetachment by high power diode laser stacks. The Review of scientific instruments, 86(11), 113306. https://doi.org/10.1063/1.4934873
O'Connor, A P, et al. "Generation of neutral atomic beams utilizing photodetachment by high power diode laser stacks." The Review of scientific instruments vol. 86,11 (2015): 113306. doi: https://doi.org/10.1063/1.4934873
O'Connor AP, Grussie F, Bruhns H, de Ruette N, Koenning TP, Miller KA, Savin DW, Stützel J, Urbain X, Kreckel H. Generation of neutral atomic beams utilizing photodetachment by high power diode laser stacks. Rev Sci Instrum. 2015 Nov;86(11):113306. doi: 10.1063/1.4934873. PMID: 26628128.
Copy Download .nbib Format: NLM
Near-infrared spectroscopy (NIRS) as a new tool for neuroeconomic research.

Frontiers in human neuroscience

Kopton IM, Kenning P.
PMID: 25147517
Front Hum Neurosci. 2014 Aug 07;8:549. doi: 10.3389/fnhum.2014.00549. eCollection 2014.

Over the last decade, the application of neuroscience to economic research has gained in importance and the number of neuroeconomic studies has grown extensively. The most common method for these investigations is fMRI. However, fMRI has limitations (particularly concerning...

Cite
Kopton IM, Kenning P. Near-infrared spectroscopy (NIRS) as a new tool for neuroeconomic research. Front Hum Neurosci. 2014;8:549doi: 10.3389/fnhum.2014.00549.
Kopton, I. M., & Kenning, P. (2014). Near-infrared spectroscopy (NIRS) as a new tool for neuroeconomic research. Frontiers in human neuroscience, 8549. https://doi.org/10.3389/fnhum.2014.00549
Kopton, Isabella M, and Kenning, Peter. "Near-infrared spectroscopy (NIRS) as a new tool for neuroeconomic research." Frontiers in human neuroscience vol. 8 (2014): 549. doi: https://doi.org/10.3389/fnhum.2014.00549
Kopton IM, Kenning P. Near-infrared spectroscopy (NIRS) as a new tool for neuroeconomic research. Front Hum Neurosci. 2014 Aug 07;8:549. doi: 10.3389/fnhum.2014.00549. eCollection 2014. PMID: 25147517; PMCID: PMC4124877.
Copy Download .nbib Format: NLM
Imaging inflammation in atherosclerotic plaques, targeting SST.

Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology

Meester EJ, Krenning BJ, de Blois E, de Jong M, van der Steen AFW, Bernsen MR, van der Heiden K.
PMID: 32026330
J Nucl Cardiol. 2020 Feb 05; doi: 10.1007/s12350-020-02046-y. Epub 2020 Feb 05.

BACKGROUND: Imaging Somatostatin Subtype Receptor 2 (SSTMETHODS AND RESULTS: Atherosclerotic ApoECONCLUSIONS: The results of this study indicate DOTA-JR11 as a promising ligand for visualization of atherosclerotic plaque inflammation.

Cite
Meester EJ, Krenning BJ, de Blois E, et al. Imaging inflammation in atherosclerotic plaques, targeting SST. J Nucl Cardiol. 2020;doi: 10.1007/s12350-020-02046-y.
Meester, E. J., Krenning, B. J., de Blois, E., de Jong, M., van der Steen, A. F. W., Bernsen, M. R., & van der Heiden, K. (2020). Imaging inflammation in atherosclerotic plaques, targeting SST. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, . https://doi.org/10.1007/s12350-020-02046-y
Meester, Eric J, et al. "Imaging inflammation in atherosclerotic plaques, targeting SST." Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology vol. (2020). doi: https://doi.org/10.1007/s12350-020-02046-y
Meester EJ, Krenning BJ, de Blois E, de Jong M, van der Steen AFW, Bernsen MR, van der Heiden K. Imaging inflammation in atherosclerotic plaques, targeting SST. J Nucl Cardiol. 2020 Feb 05; doi: 10.1007/s12350-020-02046-y. Epub 2020 Feb 05. PMID: 32026330.
Copy Download .nbib Format: NLM
[No title available]

The Lancet. Oncology

Strosberg JR, Caplin ME, Kunz PL, Ruszniewski PB, Bodei L, Hendifar A, Mittra E, Wolin EM, Yao JC, Pavel ME, Grande E, Van Cutsem E, Seregni E, Duarte H, Gericke G, Bartalotta A, Mariani MF, Demange A, Mutevelic S, Krenning EP.
PMID: 34793718
Lancet Oncol. 2021 Dec;22(12):1752-1763. doi: 10.1016/S1470-2045(21)00572-6. Epub 2021 Nov 15.

FUNDING: Advanced Accelerator Applications, a Novartis company.

Cite
Strosberg JR, Caplin ME, Kunz PL, et al. . Lancet Oncol. 2021;22(12):1752-1763doi: 10.1016/S1470-2045(21)00572-6.
Strosberg, J. R., Caplin, M. E., Kunz, P. L., Ruszniewski, P. B., Bodei, L., Hendifar, A., Mittra, E., Wolin, E. M., Yao, J. C., Pavel, M. E., Grande, E., Van Cutsem, E., Seregni, E., Duarte, H., Gericke, G., Bartalotta, A., Mariani, M. F., Demange, A., Mutevelic, S., Krenning, E. P. (2021). . The Lancet. Oncology, 22(12), 1752-1763. https://doi.org/10.1016/S1470-2045(21)00572-6
Strosberg, Jonathan R, et al. "." The Lancet. Oncology vol. 22,12 (2021): 1752-1763. doi: https://doi.org/10.1016/S1470-2045(21)00572-6
Strosberg JR, Caplin ME, Kunz PL, Ruszniewski PB, Bodei L, Hendifar A, Mittra E, Wolin EM, Yao JC, Pavel ME, Grande E, Van Cutsem E, Seregni E, Duarte H, Gericke G, Bartalotta A, Mariani MF, Demange A, Mutevelic S, Krenning EP. . Lancet Oncol. 2021 Dec;22(12):1752-1763. doi: 10.1016/S1470-2045(21)00572-6. Epub 2021 Nov 15. PMID: 34793718.
Copy Download .nbib Format: NLM
Dobutamine stress MRI versus threedimensional contrast echocardiography: It's all Black and White.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation

Nemes A, Geleijnse ML, van Geuns RJ, Soliman OI, Vletter WB, Krenning BJ, Ten Cate FJ.
PMID: 18665207
Neth Heart J. 2008 Jun;16(6):217-8. doi: 10.1007/BF03086148.

Dobutamine stress magnetic resonance imaging is considered the superior stress modality to detect wall motion abnormalities. In this report we demonstrate the strengths of a newly developed stress modality: dobutamine stress contrastenhanced real-time three-dimensional echocardiography. This stress modality may...

Cite
Nemes A, Geleijnse ML, van Geuns RJ, et al. Dobutamine stress MRI versus threedimensional contrast echocardiography: It's all Black and White. Neth Heart J. 2008;16(6):217-8doi: 10.1007/BF03086148.
Nemes, A., Geleijnse, M. L., van Geuns, R. J., Soliman, O. I., Vletter, W. B., Krenning, B. J., & Ten Cate, F. J. (2008). Dobutamine stress MRI versus threedimensional contrast echocardiography: It's all Black and White. Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation, 16(6), 217-8. https://doi.org/10.1007/BF03086148
Nemes, A, et al. "Dobutamine stress MRI versus threedimensional contrast echocardiography: It's all Black and White." Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation vol. 16,6 (2008): 217-8. doi: https://doi.org/10.1007/BF03086148
Nemes A, Geleijnse ML, van Geuns RJ, Soliman OI, Vletter WB, Krenning BJ, Ten Cate FJ. Dobutamine stress MRI versus threedimensional contrast echocardiography: It's all Black and White. Neth Heart J. 2008 Jun;16(6):217-8. doi: 10.1007/BF03086148. PMID: 18665207; PMCID: PMC2442665.
Copy Download .nbib Format: NLM
Autologous Lipofilling Improves Clinical Outcome in Patients With Symptomatic Dermal Scars Through Induction of a Pro-Regenerative Immune Response.

Aesthetic surgery journal

Spiekman M, Francia DL, Mossel DM, Brouwer LA, Diercks GFH, Vermeulen KM, Folkertsma M, Ghods M, Kzhyshkowska J, Klüter H, Krenning G, van der Lei B, Harmsen MC.
PMID: 34270698
Aesthet Surg J. 2021 Jul 16; doi: 10.1093/asj/sjab280. Epub 2021 Jul 16.

BACKGROUND: Autologous lipofilling is emerging procedure to augment and possibly reverse dermal scars and to reduce scar-related pain, but its efficacy and mechanisms are poorly understood.OBJECTIVES: To test the hypothesis that repeated lipografts reverse dermal scars by re-initiation of...

Cite
Spiekman M, Francia DL, Mossel DM, et al. Autologous Lipofilling Improves Clinical Outcome in Patients With Symptomatic Dermal Scars Through Induction of a Pro-Regenerative Immune Response. Aesthet Surg J. 2021;doi: 10.1093/asj/sjab280.
Spiekman, M., Francia, D. L., Mossel, D. M., Brouwer, L. A., Diercks, G. F. H., Vermeulen, K. M., Folkertsma, M., Ghods, M., Kzhyshkowska, J., Klüter, H., Krenning, G., van der Lei, B., & Harmsen, M. C. (2021). Autologous Lipofilling Improves Clinical Outcome in Patients With Symptomatic Dermal Scars Through Induction of a Pro-Regenerative Immune Response. Aesthetic surgery journal, . https://doi.org/10.1093/asj/sjab280
Spiekman, Maroesjka, et al. "Autologous Lipofilling Improves Clinical Outcome in Patients With Symptomatic Dermal Scars Through Induction of a Pro-Regenerative Immune Response." Aesthetic surgery journal vol. (2021). doi: https://doi.org/10.1093/asj/sjab280
Spiekman M, Francia DL, Mossel DM, Brouwer LA, Diercks GFH, Vermeulen KM, Folkertsma M, Ghods M, Kzhyshkowska J, Klüter H, Krenning G, van der Lei B, Harmsen MC. Autologous Lipofilling Improves Clinical Outcome in Patients With Symptomatic Dermal Scars Through Induction of a Pro-Regenerative Immune Response. Aesthet Surg J. 2021 Jul 16; doi: 10.1093/asj/sjab280. Epub 2021 Jul 16. PMID: 34270698.
Copy Download .nbib Format: NLM
ENETS standardized (synoptic) reporting for molecular imaging studies in neuroendocrine tumours.

Journal of neuroendocrinology

Hicks RJ, Dromain C, de Herder WW, Costa FP, Deroose CM, Frilling A, Koumarianou A, Krenning EP, Raymond E, Bodei L, Sorbye H, Welin S, Wiedenmann B, Wild D, Howe JR, Yao J, O'Toole D, Sundin A, Prasad V.
PMID: 34668262
J Neuroendocrinol. 2021 Sep 07;e13040. doi: 10.1111/jne.13040. Epub 2021 Sep 07.

The European Neuroendocrine Tumor Society (ENETS) promotes practices and procedures that aim to improve the standard of care delivered to patients diagnosed with or suspected of having neuroendocrine neoplasia (NEN). At its annual Scientific Advisory Board Meeting in 2018,...

Cite
Hicks RJ, Dromain C, de Herder WW, et al. ENETS standardized (synoptic) reporting for molecular imaging studies in neuroendocrine tumours. J Neuroendocrinol. 2021;e13040doi: 10.1111/jne.13040.
Hicks, R. J., Dromain, C., de Herder, W. W., Costa, F. P., Deroose, C. M., Frilling, A., Koumarianou, A., Krenning, E. P., Raymond, E., Bodei, L., Sorbye, H., Welin, S., Wiedenmann, B., Wild, D., Howe, J. R., Yao, J., O'Toole, D., Sundin, A., & Prasad, V. (2021). ENETS standardized (synoptic) reporting for molecular imaging studies in neuroendocrine tumours. Journal of neuroendocrinology, e13040. https://doi.org/10.1111/jne.13040
Hicks, Rodney J, et al. "ENETS standardized (synoptic) reporting for molecular imaging studies in neuroendocrine tumours." Journal of neuroendocrinology vol. (2021): e13040. doi: https://doi.org/10.1111/jne.13040
Hicks RJ, Dromain C, de Herder WW, Costa FP, Deroose CM, Frilling A, Koumarianou A, Krenning EP, Raymond E, Bodei L, Sorbye H, Welin S, Wiedenmann B, Wild D, Howe JR, Yao J, O'Toole D, Sundin A, Prasad V. ENETS standardized (synoptic) reporting for molecular imaging studies in neuroendocrine tumours. J Neuroendocrinol. 2021 Sep 07;e13040. doi: 10.1111/jne.13040. Epub 2021 Sep 07. PMID: 34668262.
Copy Download .nbib Format: NLM
Imaging inflammation in atherosclerotic plaques, targeting SST.

Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology

Meester EJ, Krenning BJ, de Blois E, de Jong M, van der Steen AFW, Bernsen MR, van der Heiden K.
PMID: 32026330
J Nucl Cardiol. 2021 Dec;28(6):2506-2513. doi: 10.1007/s12350-020-02046-y. Epub 2020 Feb 05.

BACKGROUND: Imaging Somatostatin Subtype Receptor 2 (SSTMETHODS AND RESULTS: Atherosclerotic ApoECONCLUSIONS: The results of this study indicate DOTA-JR11 as a promising ligand for visualization of atherosclerotic plaque inflammation.

Cite
Meester EJ, Krenning BJ, de Blois E, et al. Imaging inflammation in atherosclerotic plaques, targeting SST. J Nucl Cardiol. 2020;28(6):2506-2513doi: 10.1007/s12350-020-02046-y.
Meester, E. J., Krenning, B. J., de Blois, E., de Jong, M., van der Steen, A. F. W., Bernsen, M. R., & van der Heiden, K. (2021). Imaging inflammation in atherosclerotic plaques, targeting SST. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 28(6), 2506-2513. https://doi.org/10.1007/s12350-020-02046-y
Meester, Eric J, et al. "Imaging inflammation in atherosclerotic plaques, targeting SST." Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology vol. 28,6 (2021): 2506-2513. doi: https://doi.org/10.1007/s12350-020-02046-y
Meester EJ, Krenning BJ, de Blois E, de Jong M, van der Steen AFW, Bernsen MR, van der Heiden K. Imaging inflammation in atherosclerotic plaques, targeting SST. J Nucl Cardiol. 2021 Dec;28(6):2506-2513. doi: 10.1007/s12350-020-02046-y. Epub 2020 Feb 05. PMID: 32026330.
Copy Download .nbib Format: NLM
Towards prevention of ischemia-reperfusion kidney injury: Pre-clinical evaluation of 6-chromanol derivatives and the lead compound SUL-138.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Vogelaar PC, Nakladal D, Swart DH, Tkáčiková Ľ, Tkáčiková S, van der Graaf AC, Henning RH, Krenning G.
PMID: 34610451
Eur J Pharm Sci. 2021 Oct 03;168:106033. doi: 10.1016/j.ejps.2021.106033. Epub 2021 Oct 03.

Acute kidney injury (AKI) is a global healthcare burden attributable to high mortality and staggering costs of dialysis. The underlying causes of AKI include hypothermia and rewarming (H/R), ischemia/reperfusion (I/R), mitochondrial dysfunction and reactive oxygen species production. Inspired by...

Cite
Vogelaar PC, Nakladal D, Swart DH, et al. Towards prevention of ischemia-reperfusion kidney injury: Pre-clinical evaluation of 6-chromanol derivatives and the lead compound SUL-138. Eur J Pharm Sci. 2021;168:106033doi: 10.1016/j.ejps.2021.106033.
Vogelaar, P. C., Nakladal, D., Swart, D. H., Tkáčiková, �. �., Tkáčiková, S., van der Graaf, A. C., Henning, R. H., & Krenning, G. (2021). Towards prevention of ischemia-reperfusion kidney injury: Pre-clinical evaluation of 6-chromanol derivatives and the lead compound SUL-138. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 168106033. https://doi.org/10.1016/j.ejps.2021.106033
Vogelaar, P C, et al. "Towards prevention of ischemia-reperfusion kidney injury: Pre-clinical evaluation of 6-chromanol derivatives and the lead compound SUL-138." European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences vol. 168 (2021): 106033. doi: https://doi.org/10.1016/j.ejps.2021.106033
Vogelaar PC, Nakladal D, Swart DH, Tkáčiková Ľ, Tkáčiková S, van der Graaf AC, Henning RH, Krenning G. Towards prevention of ischemia-reperfusion kidney injury: Pre-clinical evaluation of 6-chromanol derivatives and the lead compound SUL-138. Eur J Pharm Sci. 2021 Oct 03;168:106033. doi: 10.1016/j.ejps.2021.106033. Epub 2021 Oct 03. PMID: 34610451.
Copy Download .nbib Format: NLM
A Delphic consensus assessment: imaging and biomarkers in gastroenteropancreatic neuroendocrine tumor disease management.

Endocrine connections

Oberg K, Krenning E, Sundin A, Bodei L, Kidd M, Tesselaar M, Ambrosini V, Baum RP, Kulke M, Pavel M, Cwikla J, Drozdov I, Falconi M, Fazio N, Frilling A, Jensen R, Koopmans K, Korse T, Kwekkeboom D, Maecke H, Paganelli G, Salazar R, Severi S, Strosberg J, Prasad V, Scarpa A, Grossman A, Walenkamp A, Cives M, Virgolini I, Kjaer A, Modlin IM.
PMID: 27582247
Endocr Connect. 2016 Sep;5(5):174-87. doi: 10.1530/EC-16-0043. Epub 2016 Aug 31.

The complexity of the clinical management of neuroendocrine neoplasia (NEN) is exacerbated by limitations in imaging modalities and a paucity of clinically useful biomarkers. Limitations in currently available imaging modalities reflect difficulties in measuring an intrinsically indolent disease, resolution...

Cite
Oberg K, Krenning E, Sundin A, et al. A Delphic consensus assessment: imaging and biomarkers in gastroenteropancreatic neuroendocrine tumor disease management. Endocr Connect. 2016;5(5):174-87doi: 10.1530/EC-16-0043.
Oberg, K., Krenning, E., Sundin, A., Bodei, L., Kidd, M., Tesselaar, M., Ambrosini, V., Baum, R. P., Kulke, M., Pavel, M., Cwikla, J., Drozdov, I., Falconi, M., Fazio, N., Frilling, A., Jensen, R., Koopmans, K., Korse, T., Kwekkeboom, D., Maecke, H., Paganelli, G., Salazar, R., Severi, S., Strosberg, J., Prasad, V., Scarpa, A., Grossman, A., Walenkamp, A., Cives, M., Virgolini, I., Kjaer, A., & Modlin, I. M. (2016). A Delphic consensus assessment: imaging and biomarkers in gastroenteropancreatic neuroendocrine tumor disease management. Endocrine connections, 5(5), 174-87. https://doi.org/10.1530/EC-16-0043
Oberg, Kjell, et al. "A Delphic consensus assessment: imaging and biomarkers in gastroenteropancreatic neuroendocrine tumor disease management." Endocrine connections vol. 5,5 (2016): 174-87. doi: https://doi.org/10.1530/EC-16-0043
Oberg K, Krenning E, Sundin A, Bodei L, Kidd M, Tesselaar M, Ambrosini V, Baum RP, Kulke M, Pavel M, Cwikla J, Drozdov I, Falconi M, Fazio N, Frilling A, Jensen R, Koopmans K, Korse T, Kwekkeboom D, Maecke H, Paganelli G, Salazar R, Severi S, Strosberg J, Prasad V, Scarpa A, Grossman A, Walenkamp A, Cives M, Virgolini I, Kjaer A, Modlin IM. A Delphic consensus assessment: imaging and biomarkers in gastroenteropancreatic neuroendocrine tumor disease management. Endocr Connect. 2016 Sep;5(5):174-87. doi: 10.1530/EC-16-0043. Epub 2016 Aug 31. PMID: 27582247; PMCID: PMC5045519.
Copy Download .nbib Format: NLM
Clinical applications of somatostatin analogs.

Trends in endocrinology and metabolism: TEM

Lamberts SW, Krenning EP, Klijn JG, Reubi JC.
PMID: 18411107
Trends Endocrinol Metab. 1990 Jan-Feb;1(3):139-44. doi: 10.1016/1043-2760(90)90025-x.

The somatostatin analog Sandostatin is successfully used in the treatment of metastatic endocrine pancreatic tumors, carcinoids, and acromegaly. In addition, somatostatin receptors are also present on other tumors in man, therefore making it possible to demonstrate these tumors by...

Cite
Lamberts SW, Krenning EP, Klijn JG, et al. Clinical applications of somatostatin analogs. Trends Endocrinol Metab. 1990;1(3):139-44doi: 10.1016/1043-2760(90)90025-x.
Lamberts, S. W., Krenning, E. P., Klijn, J. G., & Reubi, J. C. (1990). Clinical applications of somatostatin analogs. Trends in endocrinology and metabolism: TEM, 1(3), 139-44. https://doi.org/10.1016/1043-2760(90)90025-x
Lamberts, S W, et al. "Clinical applications of somatostatin analogs." Trends in endocrinology and metabolism: TEM vol. 1,3 (1990): 139-44. doi: https://doi.org/10.1016/1043-2760(90)90025-x
Lamberts SW, Krenning EP, Klijn JG, Reubi JC. Clinical applications of somatostatin analogs. Trends Endocrinol Metab. 1990 Jan-Feb;1(3):139-44. doi: 10.1016/1043-2760(90)90025-x. PMID: 18411107.
Copy Download .nbib Format: NLM
Recurrent incarceration of the retroverted gravid uterus at term - two times transvaginal caesarean section: a case report.

Journal of medical case reports

van der Tuuk K, Krenning RA, Krenning G, Monincx WM.
PMID: 19946581
J Med Case Rep. 2009 Nov 03;3:103. doi: 10.1186/1752-1947-3-103.

INTRODUCTION: Persistent retroversion of a gravid uterus (incarceration) in the third trimester is an extremely rare diagnosis and is only scarcely been described. Its prevalence may lead to increased foetal mortality and maternal morbidity.CASE PRESENTATION: We present a case...

Cite
van der Tuuk K, Krenning RA, Krenning G, et al. Recurrent incarceration of the retroverted gravid uterus at term - two times transvaginal caesarean section: a case report. J Med Case Rep. 2009;3:103doi: 10.1186/1752-1947-3-103.
van der Tuuk, K., Krenning, R. A., Krenning, G., & Monincx, W. M. (2009). Recurrent incarceration of the retroverted gravid uterus at term - two times transvaginal caesarean section: a case report. Journal of medical case reports, 3103. https://doi.org/10.1186/1752-1947-3-103
van der Tuuk, Karin, et al. "Recurrent incarceration of the retroverted gravid uterus at term - two times transvaginal caesarean section: a case report." Journal of medical case reports vol. 3 (2009): 103. doi: https://doi.org/10.1186/1752-1947-3-103
van der Tuuk K, Krenning RA, Krenning G, Monincx WM. Recurrent incarceration of the retroverted gravid uterus at term - two times transvaginal caesarean section: a case report. J Med Case Rep. 2009 Nov 03;3:103. doi: 10.1186/1752-1947-3-103. PMID: 19946581; PMCID: PMC2783044.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 44 entries